Authors Promoted to the Second Voting Round of the Amedeo Prize 2008

Sorted by Category

Endocrinology and Metabolism

ID Nominee Article + Nominator(s) Journal

1001 Furuhashi, Masato Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS.
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
Nature 2007;447:959-65.
Abstract Nature

1088 Christakis, Nicholas A Christakis NA, Fowler JH.
The spread of obesity in a large social network over 32 years.
N Engl J Med 2007;357:370-9.
Abstract N Engl J Med

1430 Stark, R Stark R, Roden M.
ESCI Award 2006. Mitochondrial function and endocrine diseases.
Eur J Clin Invest 2007;37:236-48.
Abstract Eur J Clin Invest

1625 Nissen, Steven E Nissen SE, Wolski K.
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
N Engl J Med 2007;356:2457-71.
Abstract N Engl J Med

2295 Black, Dennis M Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR.
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
N Engl J Med 2007;356:1809-22.
Abstract N Engl J Med

2413 Willi, Carole Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J.
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis.
JAMA 2007;298:2654-64.
Abstract JAMA

2530 Bolen, Shari Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL.
Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
Ann Intern Med 2007;147:386-99.
Abstract Ann Intern Med

2559 Ferrannini, Ele Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, Nolan J, Walker M, Natali A, Beck-Nielsen H.
Insulin resistance, insulin response, and obesity as indicators of metabolic risk.
J Clin Endocrinol Metab 2007;92:2885-92.
Abstract J Clin Endocrinol Metab

2655 Rubino, A Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P.
Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK.
Diabet Med 2007;24:1412-8.
Abstract Diabet Med

Design:

Amedeo Prize Alert

	1001	Furuhashi, Masato	Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007;447:959-65. Abstract		Nature

	1088	Christakis, Nicholas A	Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007;357:370-9. Abstract		N Engl J Med

	1430	Stark, R	Stark R, Roden M. ESCI Award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Invest 2007;37:236-48. Abstract		Eur J Clin Invest

	1625	Nissen, Steven E	Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71. Abstract		N Engl J Med

	2295	Black, Dennis M	Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356:1809-22. Abstract		N Engl J Med

	2413	Willi, Carole	Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298:2654-64. Abstract		JAMA

	2530	Bolen, Shari	Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147:386-99. Abstract		Ann Intern Med

	2559	Ferrannini, Ele	Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, Nolan J, Walker M, Natali A, Beck-Nielsen H. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007;92:2885-92. Abstract		J Clin Endocrinol Metab

	2655	Rubino, A	Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007;24:1412-8. Abstract		Diabet Med